Baseline demographic and clinical characteristics were generally descriptively similar for patients who initiated semaglutide and tirzepatide, suggesting that these treatments are used in similar patient populations in clinical practice
Tirzepatide (Zepbound) outperformed semaglutide in trials, achieving around 2022% average weight loss at its highest dose over ~1.5 years
Possible Enforcement Measures FDA warning letters Product seizures Injunction proceedings Import restrictions Consent decrees Civil penalties Criminal enforcement actions Product recalls The severity of enforcement often depends on the nature of the violation and potential public health impact
Hypothesis The authors hypothesized that metformin may partially prevent weight regain after weight loss induced by semaglutide
If fatigue persists beyond one month or worsens, contact your PlexusDx provider to evaluate whether nutritional support, dose timing adjustments, or other factors require attention
Weve also earned the respect of the legal community and our satisfied clients